Phenome Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -77.34%
- Profit Growth 105.67%
- Ebitda 105.67%
- Net Worth 6.65%
- Total Assets -52.83%
About Phenome Therapeutics
Phenome Therapeutics Private Limited (PTPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2018 (Six years and eight months 23 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhaskar Cherukuvada and Shekhar Jha serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2018PTC124463
-
Company No.
124463
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Phenome Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekhar Jha
|
Director | 15-May-2018 | Current |
|
Bhaskar Cherukuvada
|
Director | 15-May-2018 | Current |
Financial Performance of Phenome Therapeutics.
Phenome Therapeutics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 77.34% decrease. The company also saw a substantial improvement in profitability, with a 105.67% increase in profit. The company's net worth moved up by a moderate rise of 6.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phenome Therapeutics?
Unlock access to Phenome Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Varaint Genomics Private LimitedShekhar Jha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phenome Therapeutics?
Unlock and access historical data on people associated with Phenome Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phenome Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phenome Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.